Sionna Therapeutics, Inc. Common Stock SION Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $64.29M+8.2% | $59.41M+14.7% | $51.79M+23.5% | $41.95M-49.9% | $83.66M+116% | ||
| $220.96M-8.5% | $241.42M-4.3% | $252.33M-5.4% | $266.75M-2.5% | $273.68M+81.3% | ||
| $2.07M-6.9% | $2.23M+3.8% | $2.14M-4.5% | $2.25M-6.1% | $2.39M-3.0% | ||
| $73.78M-0.9% | $74.42M-2.9% | $76.67M+2.6% | $74.7M-12.1% | $85.02M+315% | ||
| $305.04M-6.4% | $325.95M-3.9% | $339.27M-3.6% | $352.05M-4.8% | $369.67M+99.0% | ||
| $2.11M+174% | $769K-48.1% | $1.48M+62.0% | $914K-81.8% | $5.02M+323% | ||
| $9.78M-16.5% | $11.71M+18.9% | $9.85M+30.5% | $7.55M-20.8% | $9.53M-8.6% | ||
| $16.83M-12.0% | $19.12M+8.6% | $17.6M+12.7% | $15.62M-12.8% | $17.91M-6.2% | ||
| 500M0.0% | 500M0.0% | 500M0.0% | 500M0.0% | 500M+9,999,900% | ||
| -$283.13M-10.4% | -$256.35M-8.7% | -$235.91M-9.4% | -$215.64M-9.1% | -$197.57M-9.1% | ||
| $288.21M-6.1% | $306.83M-4.6% | $321.67M-4.4% | $336.43M-4.4% | $351.77M+315% | ||
| $305.04M-6.4% | $325.95M-3.9% | $339.27M-3.6% | $352.05M-4.8% | $369.67M+99.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Sionna Therapeutics, Inc. Common Stock cover its short-term obligations?
- Its current ratio is 22.60 — current assets exceed current liabilities.
- Where does Sionna Therapeutics, Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Sionna Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.